Girindus, the oligonucleotide business of Solvay might go back into real pharma by taking over Noxxon pharma - http://www.noxxon.com/index.php?option=com_content&view=article&id=58&Itemid=97 to leverage its manufacturing capabilities soon. Marketing of the new products might be outsourced to former Solvay reps
But is this in Europe rather than the US? I loved working for Solvay in cardio meta. I only left because I never wanted to work for Abbott, now Abvie or whatever. Please update, i would apply in a heartbeat!
